Get the Stockscreener App
0.2581
4.07%
0.0101
After Hours:
.26
0.0019
+0.74%
Mangoceuticals Inc Stock (MGRX) Forecast
The Mangoceuticals Inc (MGRX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $15.59, representing a +5,941% increase from the current price of $0.2581. The highest analyst price target is $31.08, and the lowest is $0.098.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month MGRX Price Target
Average 15.55
(+5,925% Upside)
Is Mangoceuticals Inc (MGRX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 34.80 | Neutral |
| STOCH(9,6) | 13.65 | Buy |
| STOCHRSI(14) | 31.29 | Neutral |
| MACD(12,26) | -0.0488 | Sell |
| ADX(14) | 27.67 | Sell |
| William %R | -81.85 | Buy |
| CCI(14) | -43.06 | Neutral |
Buy: 2
Sell: 2
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.2713
Sell
|
0.2791
Sell
|
| MA20 |
0.3439
Sell
|
0.3206
Sell
|
| MA50 |
0.3871
Sell
|
0.3745
Sell
|
| MA100 |
0.4087
Sell
|
0.4152
Sell
|
| MA200 |
0.412
Sell
|
0.6266
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, MGRX could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 12 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on MGRX, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 34.8 indicates that MGRX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 13.65 indicates that MGRX is oversold. This indicates that MGRX price is at or near the lowest level over a specified lookback period.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 31.29 indicates that MGRX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 27.67 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -43.06 indicates that MGRX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term MGRX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Mangoceuticals Inc financial reports and earnings history, Mangoceuticals Inc (MGRX) stock could reach $3.2563 by 2030, $46.70 by 2040 and $26.52 by 2050. See the projected annual prices until 2050 of the Mangoceuticals Inc stock below:
- Mangoceuticals Inc (MGRX) is expected to reach an average price of $33.07 in 2035, with a high prediction of $30.07 and a low estimate of $31.95. This indicates an $12,712% rise from the last recorded price of $0.2581.
- Mangoceuticals Inc (MGRX) stock is projected to chart a bullish course in 2040, with an average price target of $46.34, representing an $17,855% surge from its current level. The forecast ranges from a conservative $46.63 to a sky-high $46.70.
- Our analysts predict Mangoceuticals Inc (MGRX) to jump 14,907% by 2045, soaring from $39.12 to an average price of $38.73, potentially reaching $40.75. While $39.12 is the low estimate, the potential upside is significant.
- Mangoceuticals Inc (MGRX) stock is expected to climb by 2050, reaching an average of $25.37, a $9,728% jump from its current level. However, a wide range of estimates exists, with high and low targets of $26.52 and $25.43, respectively, highlighting the market's uncertainty.
Mangoceuticals Inc Stock (MGRX) Year by Year Forecast
Mangoceuticals Inc Stock (MGRX) Price Forecast for 2026
The predicted value for Mangoceuticals Inc (MGRX) in 2026 is set at an average of $15.59. Estimates vary from a peak of $31.08 to a trough of $0.098, indicating an +5,941% surge from the present price of $0.2581.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $0.3372 | $0.098 | $31.08 | +30.63% |
| December, 2026 | $0.6223 | $0.1203 | $4.8415 | +141.12% |
Mangoceuticals Inc Stock (MGRX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Mangoceuticals Inc (MGRX) is $9.8644, with a high forecast of $19.71 and a low forecast of $0.0149. This indicates an +3,722% increase from the last price of $0.2581.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $8.2425 | $0.0149 | $19.71 | +3,094% |
| February, 2027 | $9.6073 | $6.8212 | $14.02 | +3,622% |
| March, 2027 | $3.2509 | $0.2702 | $13.74 | +1,160% |
| April, 2027 | $2.5157 | $0.7796 | $3.787 | +874.71% |
| May, 2027 | $5.1967 | $0.4769 | $3.3444 | +1,913% |
| June, 2027 | $4.7259 | $3.7546 | $2.562 | +1,731% |
| July, 2027 | $5.4611 | $5.8427 | $6.2898 | +2,016% |
| August, 2027 | $9.1175 | $3.9521 | $8.5175 | +3,433% |
| September, 2027 | $8.2762 | $8.9452 | $8.8086 | +3,107% |
| October, 2027 | $7.2338 | $7.5803 | $7.374 | +2,703% |
| November, 2027 | $9.5253 | $9.2635 | $9.0804 | +3,591% |
| December, 2027 | $8.5865 | $9.272 | $9.4121 | +3,227% |
Mangoceuticals Inc Stock (MGRX) Price Forecast for 2028
In 2028, Mangoceuticals Inc (MGRX) is projected to reach an average price of $5.8575, with a high projection of $7.6559 and a low estimate of $4.0591. This indicates an +2,169% rise from the last price of $0.2581.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $7.7759 | $8.2559 | $7.6559 | +2,913% |
| February, 2028 | $5.5171 | $5.8621 | $7.5285 | +2,038% |
| March, 2028 | $6.5462 | $6.2424 | $5.9087 | +2,436% |
| April, 2028 | $4.3414 | $5.5414 | $6.0025 | +1,582% |
| May, 2028 | $6.2744 | $4.8612 | $5.6069 | +2,331% |
| June, 2028 | $6.333 | $6.2617 | $6.1117 | +2,354% |
| July, 2028 | $7.1495 | $6.4591 | $6.6895 | +2,670% |
| August, 2028 | $7.0546 | $7.1746 | $7.0736 | +2,633% |
| September, 2028 | $6.5198 | $6.6598 | $6.7559 | +2,426% |
| October, 2028 | $6.1813 | $6.2563 | $6.3611 | +2,295% |
| November, 2028 | $5.3264 | $5.7113 | $5.8223 | +1,964% |
| December, 2028 | $3.9066 | $4.0591 | $3.8727 | +1,414% |
Mangoceuticals Inc Stock (MGRX) Price Forecast for 2029
The 2029 price forecast for Mangoceuticals Inc Stock (MGRX) is $4.1602 on average, with a high prediction of $5.5534 and a low estimate of $2.7669. This represents an +1,512% increase from the previous price of $0.2581.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.693 | $4.0092 | $5.303 | +2,106% |
| February, 2029 | $5.5182 | $5.7182 | $5.5534 | +2,038% |
| March, 2029 | $5.5434 | $5.4421 | $5.4808 | +2,048% |
| April, 2029 | $4.5398 | $4.7448 | $5.1847 | +1,659% |
| May, 2029 | $4.775 | $4.8611 | $4.7937 | +1,750% |
| June, 2029 | $4.2802 | $4.3702 | $4.3035 | +1,558% |
| July, 2029 | $3.3866 | $3.5666 | $4.024 | +1,212% |
| August, 2029 | $3.0918 | $3.2218 | $3.1075 | +1,098% |
| September, 2029 | $2.6369 | $2.7669 | $2.7581 | +921.67% |
| October, 2029 | $3.4634 | $2.9082 | $3.4134 | +1,242% |
| November, 2029 | $3.5459 | $3.351 | $3.2786 | +1,274% |
| December, 2029 | $3.3527 | $3.2507 | $3.4357 | +1,199% |
Mangoceuticals Inc Stock (MGRX) Price Forecast for 2030
Mangoceuticals Inc Stock (MGRX) is expected to reach an average price of $7.5222 in 2030, with a high forecast of $14.94 and a low forecast of $0.1053. This signifies an +2,814% surge from the last price of $0.2581.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $3.0202 | $3.2002 | $3.2563 | +1,070% |
| February, 2030 | $3.0733 | $2.983 | $2.918 | +1,091% |
| March, 2030 | $2.5805 | $2.5974 | $2.6656 | +899.81% |
| April, 2030 | $2.116 | $2.227 | $2.3418 | +719.82% |
| May, 2030 | $1.8551 | $1.8672 | $1.9867 | +618.76% |
| June, 2030 | $1.5173 | $1.5522 | $1.7235 | +487.87% |
| July, 2030 | $0.9466 | $1.1724 | $1.3486 | +266.78% |
| August, 2030 | $0.7867 | $0.8289 | $0.795 | +204.81% |
| September, 2030 | $0.3294 | $0.3854 | $0.7085 | +27.61% |
| October, 2030 | $0.1906 | $0.15 | $0.2577 | -26.14% |
| November, 2030 | $19.00 | $0.1053 | $10.30 | +7,260% |
| December, 2030 | $14.91 | $16.26 | $14.94 | +5,677% |
6.25%
5.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):